Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid

被引：25

作者：

de Mendoza, C ^{[1
]}

del Romero, J

Rodríguez, C

Corral, A

Soriano, V

机构：

[1] Hosp Carlos III, Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain

[2] Serv Reg Salud, Ctr Sanitario Sandoval, Madrid, Spain

来源：

AIDS | 2002年 / 16卷 / 13期

关键词：

D O I：

10.1097/00002030-200209060-00019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Genotypic resistance to antiretroviral drugs was analysed in plasma from 57 acute or recent HIV seroconverters in Madrid. The overall prevalence of drug-associated primary resistance mutations was 25.8% in 1997-1999, but declined to 3.8% in 2000-2001. The lower rate in recent years suggested that most new HIV infections derive from viraemic individuals unaware of their HIV-positive status, rather than from those failing antiretroviral treatment. Drug-resistance testing is thus not required before beginning antiretroviral therapy.

引用

页码：1830 / 1832

页数：3

共 18 条

[1] Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid
Briones, C
Pérez-Olmeda, M
Rodríguez, C
del Romero, J
Hertogs, K
Soriano, V
[J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02) : 145 - 150
[2] Changes in the rate of genotypic resistance to antiretroviral drugs in Spain
Gallego, O
Ruiz, L
Vallejo, A
Ferrer, E
Rubio, A
Clotet, B
Leal, M
Soriano, V
[J]. AIDS, 2001, 15 (14) : 1894 - 1896
[3] Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain
Gomez-Cano, M
Rubio, A
Puig, T
Perez-Olmeda, M
Ruiz, L
Soriano, V
Pineda, JA
Zamora, L
Xaus, N
Clotet, E
Leal, M
[J]. AIDS, 1998, 12 (09) : 1015 - 1020
[4] Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
Hecht, FM
Grant, RM
Petropoulos, CJ
Dillon, B
Chesney, MA
Tian, H
Hellmann, NS
Bandrapalli, NI
Digilio, L
Branson, B
Kahn, JO
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) : 307 - 311
[5] Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel
Hirsch, MS
Brun-Vézinet, F
D'Aquila, RT
Hammer, SM
Johnson, VA
Kuritzkes, DR
Loveday, C
Mellors, JW
Clotet, B
Conway, B
Demeter, LM
Vella, S
Jacobsen, DM
Richman, DD
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18): : 2417 - 2426
[6] *INT AIDS SOC US R, 2001, HIV CLIN TRIALS, V2, P346
[7] LITTLE SJ, 2001, 8 C RETR OPP INF CHI
[8] Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management:: recommendations for the European setting
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vézinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Bànhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sönnerborg, A
Soriano, V
Steel, H
[J]. AIDS, 2001, 15 (03) : 309 - 320
[9] Pérez-Olmeda M, 2001, J MED VIROL, V63, P85, DOI 10.1002/1096-9071(20000201)63:2&lt
[10] 85::AID-JMV1000&gt

← 1 2 →